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Introduction
Eph receptor tyrosine kinases (RTKs) and their membrane-
bound ephrin ligands are key regulators of cell movement
during development (Flanagan and Vanderhaeghen, 1998;
Holder and Klein, 1999). Their interaction can lead to the
activation of bidirectional signalling pathways in ligand- and
receptor-expressing cells (Davy et al., 1999; Holland et al.,
1998). Both receptor and ligand-initiated signals mediate
repulsion, adhesion and de-adhesion mechanisms involved in
the motility of adherent cells.
Previously we showed that Eph signalling is essential
for directing the movement of cells during zebrafish
embryogenesis, disruption of the EphA3 function leading to
severe defects in gastrulation (Lackmann et al., 1998; Oates et
al., 1999). The nature of these gastrulation defects and loss of
cell adhesion in pre-gastrulation Xenopus embryos by activated
EphA4 or ectopically expressed ephrin-B (Jones et al., 1998;
Winning et al., 1996) suggests that Eph receptors and ephrins
function by modulating cell adhesion and motility (Bruckner
and Klein, 1998; Flanagan and Vanderhaeghen, 1998; Xu et al.,
2000). This notion is supported by accumulating evidence
suggesting that stimulated Eph receptors and ephrins modulate
integrin function (Becker et al., 2000; Davy et al., 1999;
Huynh-Do et al., 1999; Jones et al., 1998; Wahl et al., 2000;
Winning et al., 1996; Zisch et al., 2000; Zou et al., 1999). 
Eph receptor activation leads to tyrosine phosphorylation of
three major autophosphorylation sites, two of which are
located in the highly conserved juxtamembrane region, and a
third in the activation loop of the kinase domain. Together,
these residues function to regulate kinase activity, their
phosphorylation being required for full intrinsic enzyme
activity (Binns et al., 2000; Zisch et al., 2000). The
juxtamembrane tyrosines are also likely to be important for
signal transfer, and were suggested as docking sites for known
signalling molecules including Fyn, Src, Ras GTPase-
activating protein (RasGAP), SHEP-1 and Nck (reviewed by
Mellitzer et al., 2000). The involvement of most of these
molecules in the organisation of the cytoskeleton
(Schoenwaelder and Burridge, 1999; Schlaepfer and Hunter,
1998) supports an emerging concept from functional
experiments of a direct communication between activated Eph
receptors and signalling pathways regulating cell adhesion and
plasticity of the actin cytoskeleton (Schmucker, 2001).
The reorganisation of cell morphology during adhesion and
detachment involves changes in focal adhesion complexes and
in the actin/myosin cytoskeleton and is regulated principally
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Eph receptor tyrosine kinases and ephrins regulate
morphogenesis in the developing embryo where they effect
adhesion and motility of interacting cells. Although
scarcely expressed in adult tissues, Eph receptors and
ephrins are overexpressed in a range of tumours. In
malignant melanoma, increased Eph and ephrin expression
levels correlate with metastatic progression. We have
examined cellular and biochemical responses of EphA3-
expressing melanoma cell lines and human epithelial
kidney 293T cells to stimulation with polymeric ephrin-A5
in solution and with surfaces of defined ephrin-A5
densities. Within minutes, rapid reorganisation of the actin
and myosin cytoskeleton occurs through activation of
RhoA, leading to the retraction of cellular protrusions,
membrane blebbing and detachment, but not apoptosis.
These responses are inhibited by monomeric ephrin-A5,
showing that receptor clustering is required for this EphA3
response. Furthermore, the adapter CrkII, which
associates with tyrosine-phosphorylated EphA3 in vitro,
is recruited in vivo to ephrin-A5-stimulated EphA3.
Expression of an SH3-domain mutated CrkII ablates cell
rounding, blebbing and detachment. Our results suggest
that recruitment of CrkII and activation of Rho signalling
are responsible for EphA3-mediated cell rounding,
blebbing and de-adhesion, and that ephrin-A5-mediated
receptor clustering and EphA3 tyrosine kinase activity are
essential for this response. 
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tyrosine kinases, Melanoma, Metastasis
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by signals emanating from clustered cell adhesion receptors.
Members of the Ras/Rho families of GTPases are essential in
these pathways (reviewed by Hall, 1998; Schoenwaelder and
Burridge, 1999), as they relay signals from various growth
factor or integrin-derived pathways to effect characteristic
changes to the cell morphology. The Crk family of adapter
proteins (Matsuda et al., 1992) are also intimately involved in
signal-transduction processes regulating integrin-dependent
cell adhesion (Vuori et al., 1996; Zvara et al., 2001) and
migration (Arai et al., 1999; Klemke et al., 1998; Petit et al.,
2000). Via its src homology, SH2 and SH3 domains, Crk
interacts with downstream signalling molecules including c-
Abl, p130CAS (Crk-associated substrate), paxillin, Cbl, C3G
and DOCK 180 (reviewed by Feller et al., 1998). 
Although the integrin-mediated interaction with the
extracellular matrix is essential for migration and survival of
adherent cells, the deregulated adhesion or loss of adhesion
dependence is a hallmark of tumour progression and
metastasis (Giancotti and Ruoslahti, 1999). It is now well
established that tumour progression in human cutaneous
melanoma correlates with integrin expression and function
(Johnson, 1999; Seftor et al., 1999). Intriguingly, several Eph
receptors and ephrins are overexpressed in tumour specimens
and tumour cell lines (reviewed by Dodelet and Pasquale,
2000). Moreover, increased expression levels of EphA2,
EphA3, ephrin-A1 and ephrin-B2 correlate with melanoma
tumorigenesis and metastatic progression (Chiari et al., 2000;
Easty et al., 1995; Easty et al., 1999; Vogt et al., 1998). Given
their essential function in regulating cell motility and
adhesion during normal development, it is possible that the
prometastatic effects of Eph/ephrin overexpression in
tumours are due to changes in cell adhesion and motility that
facilitate tumour cell dislodgement and invasion. To test this
notion we studied the responses of EphA3-expressing
melanoma cell lines and EphA3-transfected 293T cells
(human kidney epithelial 293T cells) to ephrin-A5
stimulation and its impact on changes in cell adhesion and
actin cytoskeletal organization.
We show that EphA3 activation induces retraction of cell
protrusions, cell rounding, membrane blebbing and de-
adhesion, and that ephrin-A5-mediated receptor clustering and
the tyrosine kinase activity of EphA3 are essential for this
response. By expression cloning we identify CrkII as a
cytoplasmic ligand of activated EphA3 and show that CrkII
signalling is crucial for ephrin-A5-mediated cell rounding.
EphA3 activation also results in transient activation of RhoA,
and treatment of cells with the Rho inhibitor C3-transferase or
the ROCK inhibitor Y-27623 abrogate ephrin-A5-mediated cell
rounding and membrane blebbing, respectively. A dominant-
negative, SH3 mutant CrkII abrogates both ephrin-A5-induced
cell morphological changes and RhoA activation. Our findings
suggest a pathway where ephrin-A5-induced recruitment of
CrkII to EphA3 and a rapid, transient increase in activated
RhoA result in cell rounding, membrane blebbing and
detachment.
Materials and Methods
Expression constructs and reagents
The cloning of full-length EphA3 (Wicks et al., 1992) into pEFBos
(Nicola et al., 1996) has been described previously. Mutants of full-
length EphA3 in pEFBos were prepared using the QuickChange
mutagenesis system (Stratagene). Plasmid, pEGFP(enhanced green
fluoresecent protein)-actin was from Clontech, and myc-tagged Crk
II expression constructs pCAGGS Crk and pCAGGS Crk SH3* were
a generous gift from M. Matsuda (International Medical Centre,
Japan). For the expression vector encoding the EphA3 intracellular
domain (EphA3 ID), residues 583-983 of the EphA3 receptor were
cloned into the pET32a expression vector (Novagen) between the
EcoRI and XhoI sites. The expression vector encoding TC45PTP as
a GST fusion protein (Tiganis et al., 1999) was a gift from T. Tiganis
(Monash University, Victoria, Australia). The RhoA-binding domain
(RBD) of Rhotekin was a kind gift from K. Burridge (UNC, Chapel
Hill, NC). 
Expression plasmids encoding fusion proteins in which either the
extracellular domains of ephrin-A5 or EphA3 were fused to the hinge
and Fc region of human IgG1 (gift from D. Cerretti, Immunex Corp.,
Seattle, WA) were used to transfect Chinese Hamster Ovary (CHO)
cells. EphA3-Fc and Ephrin-A5 Fc (fusion protein between the Fc
portion of human IgG and the C-terminus of ephrin-A5) were purified
from cell culture supernatants by protein-A affinity chromatography.
Flag-tagged monomeric ephrin-A5 was purified to homogeneity from
transfected CHO cell supernatants as described previously (Lackmann
et al., 1997). To facilitate formation of clustered ephrin-A5, ephrin-
A5 Fc was incubated (20 minutes) at 1/10 molar ratio with anti-human
Fc antibody (Jackson Laboratories). 
A native EphA3-specific (clone IIIA4) monoclonal antibody
(Mab) and affinity-purified rabbit polyclonal antibodies have been
described previously (Boyd et al., 1992; Lackmann et al., 1997).
Anti-myc 9E10 antibodies were a generous gift from E. Stanley
(WEHI, Melbourne, Australia). Additional antibodies and reagents
were purchased from Transduction Laboratories (focal adhesion
kinase, Crk and p130CAS), New England Biolabs and Upstate
Biotechnology (phosphotyrosine), Santa Cruz (RhoA), BD
Pharmingen (annexinV-FITC), and Sigma ( a -tubulin), HRP-labelled
secondary antibodies from Jackson laboratories (anti-mouse) and
Bio-Rad (anti-rat), Alexa-labelled antibodies and rhodamine-
phalloidin from Molecular Probes.
Cell culture and microscopy
The AO2 and AO9 melanoma cells lines were obtained as clones of
adherent cells derived from mechanically dispersed deposits of
secondary metastatic melanomas (M. D., C. W. Schmidt, M.
O’Rourke, unpublished). LiBr secondary malignant melanoma cells
were described previously (Coates and Crawford, 1977). Melanoma
cells were cultured in RPMI, 10% iron-fortified fetal bovine serum.
Human kidney epithelial (HEK) 293T cells were maintained in DME,
10% fetal calf serum (FCS). Transient transfection with the various
expression constructs was carried out using Fugene 6 (Roche
Biochemicals).
To study stimulation in situ, melanoma or 293T cells were seeded
onto fibronectin-coated round glass coverslips in 6-well dishes. 293T
cells were transfected with the various expression constructs or
the w/t EphA3 or pEGFP-actin, or both, using Fugene. Before
examination, the cells were kept in DME, 1% FCS for at least 3 hours.
For analysis on a Bio-Rad 1024 confocal microscope, coverslips were
placed in Sykes Moore chambers (Sykes and Moore, 1959) and
images taken every minute, 10 minutes before and 50 minutes after
the addition of ligand or control solution. 
For immunocytochemistry, cells on coverslips were washed with
PBS, fixed with 4% para-formaldehyde in PBS for 10 minutes and
permeabilised with 0.5% Triton X100 for 5 minutes before blocking
for 30 minutes in PBS/0.2%BSA. Cells were incubated with relevant
antibodies as indicated in figure legends, washed with PBS and
incubated with Alexa-labelled secondary antibodies. For actin
staining, permeabilised cells were stained with rhodamine-labelled
phalloidin (0.1 m g/ml).
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Adhesion assays 
Ephrin-coated surfaces were prepared by immobilising ephrin-A5 Fc
onto ‘Reacti-Bind’ Protein A coated plates (Pierce). Wells were washed
with PBS/0.1%Tween 20 (PBST) before incubating overnight at 4°C
with ephrin-A5 Fc in PBST/0.1% BSA at concentrations as indicated.
Nonbound ephrin-A5 Fc was recovered for analysis and the plate was
washed extensively before seeding cells. The density of bound ephrin-
A5 Fc was calculated using Biacore analysis (Biacore AB) by estimating
the ephrin-A5 concentration in nonbound fractions with a sensor chip
containing EphA3 extracellular domain (Lackmann et al., 1997). The
ability of Protein-A-tethered ephrin-A5 to bind EphA3 was confirmed
by applying a constant concentration of the soluble EphA3 extracellular
domain to wells of increasing ephrin-A5 densities and estimating the
fraction of nonbound EphA3 by Biacore analysis as described
(Lackmann et al., 1998). 
Before seeding cells, residual Fc binding sites in wells were blocked
by incubation with culture media containing 10% FCS. Cells were
seeded (3· 104 cells/well) onto the plates and allowed to adhere for 6
hours before fixation in 4% paraformaldehyde for microscopy. Adherent
cells were stained with 0.5% crystal violet, solubilised in 0.1% SDS,
and quantified by measuring the OD at 570 nm of individual wells in a
microtiter plate reader. Each value represents the mean and s.d. from
absorbance readings of triplicate wells made in parallel. 
Melanoma cells cultured in 96-well plates were stimulated with
preclustered ephrin-A5. Following PBS washes, adherent cells were
fixed with 4% paraformaldehyde and quantified by crystal violet
staining as described above.
Cell viability and apoptosis assays
Cell viability was assessed by vital dye (0.5% trypan blue) exclusion
and apoptotic cells quantified by flow cytometric analysis using
established methods, including annexinV-FITC cell membrane
staining and examination of nuclear condensation as described
(Vermes et al., 2000). Briefly, combined adherent and detached cells
from cultures of adherent cells, treated for 4 hours or as indicated with
preclustered (see below) ephrin-A5 Fc or with staurosporin (Sigma),
were washed once with PBS before incubation either in Ca2+-
containing buffer with 1 m g/ml FITC-annexin and 1 m g/ml propidium
iodide (PI), or after permeabilisation in 0.2% Triton-X100/0.1%
sodium acetate, pH 6.0 with 50 m g/ml PI. In the latter assay, apoptotic
cells are characterised by a PI staining intensity of their nuclei that is
lower than that of normal cells. Viable and apoptotic cells were
quantified by flow cytometry.
Immunoprecipitation and western blotting
Cells were serum starved for 4 hours in DME/1% FCS. After 10
minutes stimulation with preclustered ephrin-A5 (1.5 m g/ml or as
indicated in figure legends), cells were lysed in 50 mM Tris, pH 7.4,
150 mM NaCl, 1% Triton X100, 1 mM NaV04, 10 mM NaF and
protease inhibitors (TBS-Tx100). Lysates were immunoprecipitated
with IIIA4 Mab coupled to Trisacryl (1 hour at room temperature or
overnight at 4°C) (Boyd et al., 1992) or with 5 m g/ml anti-CrkII Mab
and protein A Sepharose (Pharmacia). Washed (TBS-T· 100)
immunoprecipitates were analysed by western analysis with
appropriate antibodies. Blots were visualised using an ECL substrate
(Pierce). 
Assay for GTP-bound RhoA and ADP-ribosylation of RhoA by
C3-exoenzyme
RBD was expressed as GST fusion proteins in BL21 cells. The levels
of GTP-bound RhoA in cell lysates were measured as previously
described (Schoenwaelder et al., 2000), according to Ren et al. (Ren
et al., 1999), except that cells were lysed in TBS-T· 100, and the NaCl
and MgCl2 concentrations were adjusted to 500 mM and 10 mM,
respectively, before the addition of the beads. ADP-ribosylation of
RhoA in cell extracts was analysed as described previously (Leng et
al., 1998). Briefly, EphA3-293T cells (60-70% confluent), after 15-20
hours incubation with 10 m g/ml C3 exoenzyme, were rinsed with PBS
and lysed on ice in buffer containing 1.5% Triton X-100, 0.8% DOC,
0.2% SDS, 145 mM NaCl, 20 mM Hepes, pH 7.4, 3 mM EGTA, 2
mM MgCl2, 25 m g/ml PMSF, 5 m g/ml leupeptin, 5 m g/ml aprotinin.
Control cells were supplemented with an appropriate amount of C3
before washing and lysis. In vitro ADP-ribosylation was performed
immediately at 30°C for 60 minutes on 50 m g samples of total cell
lysate by the addition of 200 m M GTP, 10 m M NAD+, 10 m g/ml C3
exoenzyme and 0.5-2.5 m Ci/assay 32P NAD+. Reactions were
terminated by the addition of sample buffer, boiled and analysed on
SDS-PAGE, followed by autoradiography.
Bacterial expression of EphA3 ID and protein expression
library screen
EphA3 ID constructs were transformed into Escherichia coli
BL21(DE3). After overnight induction at 16°C, cell pellets were
sonicated in phosphate buffer pH 8.0, 300 mM NaCl, 10 mM
imidazole, pH 8, 10 mM b -mercaptoethanol and protease inhibitors
(EDTA-free ‘Complete’, Roche Biochemicals), cleared lysates
applied to Ni-NTA Fast Flow resin (Qiagen) and bound protein eluted
with 500 mM imidazole in the above buffer. Thioredoxin and His
Tags were cleaved from the eluted protein in 10 mM Tris, 150 mM
NaCl, 2mM CaCl2 with enterokinase (Novagen) for 8 hours.
Impurities and thioredoxin/His tags were removed by re-application
to Ni NTA, the EphA3 ID remaining in the unbound fraction. All
experiments were performed with enterokinase cleaved EphA3 ID.
A 16 day mouse embryo cDNA library in l Exlox (Novagen) was
used to identify potential signalling partners of EphA3.
Approximately 2 · 105 independent clones from the library were
screened according to the manufacturer’s instructions. Briefly, cDNA
clones were immobilised on nitrocellulose filters (Osmonics), which
were washed and blocked with PBST/1% BSA and incubated with 1
m g/ml phosphorylated EphA3 ID in PBS/0.1% Triton X100/1mM
NaVO4. Clones that bound EphA3 ID were identified by incubation
with 4G10 anti-phosphotyrosine (PY) antibody and HRP-conjugated
anti-mouse antibody, visualised with ECL (Amersham Pharmacia
Biotech). Positive clones were plaque purified and their cDNA inserts
rescued by auto-subcloning in pExlox. The cDNA inserts were
sequenced and the proteins identified using BLAST 2.0 (Altschul et
al., 1997).
Mapping of EphA3 derived phosphopeptides and
phosphopeptide synthesis
EphA3 ID was dephosphorylated by the addition of TC45PTP linked
to glutathione Sepharose overnight at 4°C. Phosphorylated and
dephosphorylated EphA3 ID were purified by reverse phase HPLC
and recovered proteins digested with TPCK-treated trypsin (Roche
Biochemicals). Tryptic peptides were fractionated by C18 reverse
phase HPLC (2.1 · 250 mm, Vydac) with a 90 minute gradient of 60%
CH3CN in 0.1% trifluoroacetic acid and individual peptides recovered
manually according to their 214 and 280 nm absorbances. Tyrosine
phosphopeptides, identified by their altered retention were analysed
by MALDI/MS as described (Reid et al., 1998). 
Tyrosine phosphorylated (P) peptides corresponding to Lys589-
Glu611 of the juxtamembrane domain and to Asp773-Ile788 of the
activation loop of EphA3 were synthesised by solid-phase chemistry,
and purity (>98%) and integrity confirmed by electro-spray mass







Stimulation with ephrin-A5 causes retraction of cell
processes and de-adhesion of EphA3-expressing
melanoma cell lines
Tumour-specific EphA3 expression has been documented in
human malignant melanoma and elevated EphA3 levels have
been found in 72% of human melanoma lines (Chiari et al.,
2000). By comparing the expression levels of EphA3 in several
human melanoma cells we selected two recently isolated lines,
AO2 and AO9 (M. D. and A. W. B., unpublished), and the
previously established LiBr cell line (Coates and Crawford,
1977) for further examination. Using the anti-EphA3 Mab IIIA4
for flow cytometric analysis indicated significant EphA3
expression levels on LiBr and AO9 cells (Fig. 1Ac,e), whereas
no immunoreactivity was detected on AO2 melanoma cells (Fig.
1Ab). Using a chimeric EphA3 Fc fusion protein for detection,
we also observed significant expression of ephrin-A on LiBr
cells (Fig. 1Ad), but not on AO2, AO9 (not shown) or 293T cells
(Fig. 1Af). Northern blot analysis confirmed matching levels of
EphA3 mRNA in these cells (Fig. 1B). Before treatment with
preclustered ephrin-A5 Fc, the majority of cells from all three
lines formed flat, +/– spindle-shaped, adherent cell bodies (Fig.
2A) with extensive, dendritic processes containing actin stress
fibres (Fig. 2B). Some rounded melanoma cells are routinely
found in less-strongly adherent melanoma cell lines, including
LiBr cultures. Within 10-30 minutes after stimulation with
clustered ephrin-A5 we observed retraction of cell processes and
cell rounding in previously elongated, spindle-shaped cells (Fig.
2A,B). These changes in cell morphology were accompanied by
redistribution of polymerised actin into dense cortical actin rings
(Fig. 2B). In AO9 cells, which were more spread-out and
normally grow as tightly attached monolayer cultures (M. D. and
S. K., unpublished), this effect was less pronounced (Fig. 2A).
By 30 minutes only 65% of the starting LiBr population
remained attached to the tissue culture surface, whereas AO9
cells were at least weakly adherent throughout the experiment
(Fig. 2A,C). AO2 cultures, by comparison, showed no change
in morphology throughout the experiment (Fig. 2A). To show
that rounding and detachment were caused by ephrin-A5 Fc
clustering of EphA3, LiBr cells were pre-incubated with soluble,
monomeric ephrin-A5 to block available ligand binding sites.
This pretreatment abrogated cell rounding and detachment,
indicating that EphA3 clustering was required for the observed
response (Fig. 2A,C). In addition to changes in cell shape and
adhesion, extensive, dynamic membrane blebbing was observed
within 10 minutes of ephrin-A5 challenge and persisted for at
least 5 hours (Fig. 2A). Assessment of cell viability by vital dye
exclusion and annexin binding to the plasma membrane showed
that these changes to cell morphology, even after extended
treatment with ephrin-A5, are not due to apoptosis (Fig. 2D,E). 
Ephrin-A5-mediated morphological changes during de-
adhesion are differentially affected by mutation of
tyrosines within the EphA3 juxtamembrane and activation
loop domains
To examine the molecular mechanism of ephrin-A5-mediated
cell-morphological changes in more detail, we expressed w/t or
mutant EphA3 in 293T cells. Although we could not detect
endogenous ephrin-A in these cells (Fig. 1Af), they do contain
some endogenous EphA3 (Fig. 1Ag) (Dottori et al., 1999),
suggesting them as an appropriate model system for our studies.
293T cells do not display distinct actin stress fibres, but staining
of permeabilised cells with rhodamine-phalloidin and an anti-a -
tubulin antibody displays complex actin (Fig. 3A-C) and
microtubule networks (Fig. 3E), with distinct fibre bundles
extending into cell protrusions and lamellipodia. Following
exposure to ephrin-A5, nontransfected 293T cells do not change
their shape or gross morphology, and changes to the actin
cytoskeleton are unremarkable (Fig. 3B). By contrast, treatment
of w/t EphA3-transfected 293T cells with ephrin-A5 results in a
dramatic contraction of the actin and microtubule cytoskeleton
into dense fibre bundles surrounding cell nuclei (Fig. 3D,F).
Parallel staining of permeabilised cells with an anti-
phosphotyrosine Mab to outline focal adhesion complexes
suggests that cell contraction is accompanied by loss of focal
contacts and focal adhesions from the cell periphery (Fig. 3G,H).
Furthermore, examination of vertical sections suggests that
rounding and contraction of the cell body is accompanied by a
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Fig. 1. Expression levels of
EphA3 and ephrin-A on various
melanoma cell lines and 293T
cells. (A) LK63 human B-cell
leukaemia cells, melanoma cells
and 293T cells as indicated were
analysed for cell-surface
expression of EphA3 (a-c,e,g,h)
with IIIA4 anti-EphA3
monoclonal antibody (solid lines)
or an IgG1 isotype matched
nonrelevant control antibody
(broken lines), and of ephrin-A5
(d,f) with an EphA3-human Fc
fusion protein (solid lines) or with
EphA1-human Fc fusion protein
(broken lines). Analysed cell
populations were gated to exclude
propidium iodide (PI)-positive
dead cells. FITC-labelled sheep anti-mouse antibodies and anti-human Fc antibodies (both Jackson
Laboratories) were used for visualisation. (B) Expression of EphA3 in melanoma cell lines was examined
by northern blot analysis. LK63 human B-cell leukaemia cells were used as positive control (lane1); LiBr
cells (lane 2), AO2 cells (lane 3), AO9 cells (lane 4). The 28S mRNA is shown as loading control.
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substantial gain in cell height and is not due to a net loss in cell
volume (Fig. 3I,J).
We addressed the dependence of these cellular effects on
EphA3 kinase activity and tyrosine phosphorylation within the
EphA3 cytoplasmic domain by examining the effects of
phenylalanine mutants of the conserved juxtamembrane
tyrosines, Y596 and Y602, and of Y779, which is located within
the activation loop of the kinase. Immunoblot analysis of parallel
cell lysates indicated that these three tyrosine residues
correspond to the major EphA3 phosphorylation sites of the
receptor and that w/t and mutant receptors were expressed at
comparable levels in transfected cells (see below, Fig. 6E).
Cotransfection with an enhanced green fluorescent actin fusion
protein (EGFP-actin) enabled the examination, by time-lapse
fluoresence microscopy, of cell morphology changes resulting
from ephrin-A5 stimulation of w/t or mutant EphA3-transfected
cells. Expression of EGFP-actin on its own had no effect on the
cell morphology or the expression levels of endogenous actin in
transfected cells (Ballestrem et al., 1998). In agreement, our
293T cells did not change their shape or actin cytoskeleton upon
ligand stimulation (Fig. 4B, EGFP-actin). In the absence of
ephrin-A5 stimulation w/t EphA3-transfected cells were flat, and
spread out on the fibronectin-coated glass slide (Fig. 4, w/t,
0 minutes). They started to retract their extensions and
lamellipodia 5-10 minutes after ligand addition (Fig. 4, w/t, 10).
Concurrently, dynamic blebbing of the cell membrane occurred
with increasing intensity and by 50 minutes many of the cells
revealed membrane blebs as indicated by globular, actin-
containing membrane protrusions surrounding the cells (Fig. 4A,
w/t, 50). At this time, transfected cells started to detach, and by
50 minutes more than 50% of cells within the selected,
representative field had moved out of the focal plane. Again, this
response was not due to apoptosis (Fig. 2D). Importantly,
addition of soluble, monomeric ephrin-A5 blocks the response
Fig. 2. Melanoma cell rounding, de-adhesion and membrane
blebbing induced by clustered ephrin-A5 Fc is inhibited by
soluble, monomeric ephrin-A5. (A) LiBr, AO9 and AO2
melanoma cells on fibronectin-coated glass coverslips were
stimulated with 10 nM clustered ephrin-A5 Fc. Soluble,
monomeric ephrin-A5 was added as inhibitor (+ inhibitor) to a
parallel LiBr culture at 100-fold molar excess. Selected pictures
of representative microscopic images taken during a 50 minute
time course are shown. Arrowheads denote cells that retract their
processes and round up during stimulation. Bar, 20 m m. A
supplemental video of the AO9 time course is available at:
http://www.ludwig.edu.au/addinfo/Figure2_AO9.mpg. (B) LiBr
melanoma cells on fibronectin-coated glass coverslips before (–)
or after (+) 10 minute ephrin-A5 stimulation were fixed,
permeabilised and stained with rhodamine-phalloidin to
visualise polymerised actin. Bar, 20 m m. (C) Melanoma cells on
fibronectin-coated 96-well plates were treated as decribed in (A)
and at indicated times cells were fixed and stained with crystal
violet. Values represent mean A550 absorbances from
quadruplicate wells ±s.d.: j, LiBr cells; m, AO9 cells; n, LiBr
cells with inhibitor; d, AO2 cells. (D) Ephrin-A5 treatment does
not impair cell viability in LiBr or EphA3 293T cells. Cultures
of LiBr (grey bars) or EphA3 293T (black bars) cells in 24-well
plates were treated with preclustered human IgG
(control) or ephrin-A5 for 2 hours at 37°C, detached
by EDTA treatment and cell viability in
quadruplicate samples determined by trypan blue
exclusion assay. To induce apoptosis, cells in
parallel wells were treated for 4 hours with 1 m M
staurosporin (St.sp.) or 0.5 mM H2O2. Control cells
in parallel wells were treated for 30 minutes with the
caspase inhibitor zVAD-fmk (0.1 mM) before
addition of the apoptotic reagent. (E) Ephrin-A5
stimulation of LiBr cells does not result in increased
numbers of apoptotic cells. LiBr monolayer cultures
were treated for 2 hours at 37°C with (a), 1.5 m g/ml
or (b), 7.5 m g/ml pre-clustered ephrin-A5 Fc; (c) 7.5
m g/ml preclustered control IgG; and (d) 1 m M
staurosporin. Cells in the supernatant and detached
by trypsin/versene treatment were combined, washed
in Annexin V binding buffer and analysed for
binding of Annexin V to the outer plasma membrane
(apoptosis) and propidium iodide (PI) uptake
(necrosis) by flow cytometry. Viable cells (lower left
quadrant) are negative for Annexin V and PI,
apoptotic cells (upper left quadrant) are positive for
Annexin V, necrotic cells (upper right quadrant) are
positive for Annexin V and PI.
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to ephrin-A5 Fc and cells did not change their morphology
throughout the time course of the experiment (Fig. 4B, w/t +
Inhibitor).
Mutation of either of the juxtamembrane tyrosines, Y559 or
Y602, retarded the onset of cell rounding to about 20 minutes
after stimulation. Although pronounced membrane blebbing was
still apparent in Y559 EphA3-expressing cells after 50 minutes
(Fig. 4A, Y559F, 50), blebbing was abrogated in Y602 EphA3-
expressing cells (Fig. 4B, Y602F, 50). Mutation of both tyrosines
together, or of the EphA3 activation loop tyrosine, Y779,
profoundly affected the cellular responses to ephrin-A5 (Fig.
4B), the cells showing no alterations to their shape or actin
distribution throughout the experiment. Transfection of cells
with EphA3 harbouring mutations in all three tyrosines (3· YF)
affected the cell morphology independent of ephrin-A5
stimulation (Fig. 4B, 3YF). The cells, which display thin,
dendrite-like processes remained adherent and did not
significantly change their morphology during the time course of
the experiment. 
Surface-bound Ephrin-A5 Fc impairs adhesion and
spreading in 293T cells expressing wild-type but not
mutant EphA3
We sought to examine whether EphA3 activation by surface-
bound ephrin-A5 would affect the re-adhesion of detached 293T
cells. To mimic activation of EphA3 by its cell membrane-bound
ligand in vitro, chimeric ephrin-A5 Fc was coupled to protein-
A-coated 96-well plates via its C-terminal Fc domain. Biacore
analysis of the nonbound fractions with an EphA3-coated sensor
chip suggested a surface capacity of 0.2 m g ephrin-A5 Fc/well.
We also applied the soluble EphA3 extracellular domain to the
ephrin-A5-coated surface, and by measuring the nonbound
EphA3 in the supernatant confirmed that the immobilised
ephrin-A5 is in a biologically active form, capable of interacting
with the receptor (Fig. 5A). Although exposure of 293T cells,
transfected with EGFP-actin, to ephrin-A5 had no measurable
effect on adhesion, w/t EphA3-expressing cells remained round
and failed to adhere to surfaces of increasing coating density of
ephrin-A5 (Fig. 5B,C). The effect was noticeable even at the
lowest ephrin-A5 density tested (8 pg/mm2). At a density of 0.18
ng/mm2, corresponding to an ephrin-A5 Fc concentration of 2
nM, only approximately 50% of the cells were able to attach. 
Mutation to phenylalanine of single EphA3 juxtamembrane
tyrosines Y596 or Y602 reduced the number of nonadherent
cells. The effect of the Y602F mutation was more potent than
the Y596 mutation, with more cells adhering to the ephrin-A5
surface. Mutation of both juxtamembrane tyrosines or the
activation loop tyrosine Y779 or of all three tyrosines (Y596,
Y602 and Y779) essentially ablated the response to ephrin-A5
surfaces and no significant effect of ephrin-A5 on 293T cell
adhesion was observed (Fig. 5C). Thus, at an ephrin-A5 Fc
surface density of 1.5 ng/mm2, only 30-40% of w/t EphA3-
expressing cells attached to the wells, whereas 90-95% of the
mutant Y779 EphA3 or Y596/Y602 EphA3-expressing cells
were adherent at this ephrin-A5 concentration. 
Taken together, these observations suggest that ephrin-A5-
triggered mechanisms, causing cell detachment or repulsion,
are dependent on EphA3 kinase activity and tyrosine
phosphorylation, but are independent from prior engagement of
cell adhesion mechanisms.
Identification of Crk as an interaction partner for activated
EphA3
To identify cytosolic proteins downstream from activated
EphA3, we screened a 16 day mouse embryo cDNA expression
library using recombinant phosphorylated EphA3 intracellular
domain (ID) as the probe. The soluble, tyrosine phosphorylated
fusion protein was isolated from E. coli after overexpression of
a cDNA encoding the intracellular portion of EphA3 fused to a
cleavable thioredoxin and His tag. Following dephosphorylation
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Fig. 3. Ephrin-A5-induced cell rounding involves contraction of the
actin and microtubule network and loss of peripheral focal contacts.
Parental (A,B) or EphA3-293T cells (C-J) were grown on
fibronectin-coated glass coverslips. Following stimulation with
ephrin-A5 fixed and permeabilised cells were incubated with
rhodamine-phalloidin (A-D), or primary antibodies against a -tubulin
(E,F) and phospho-tyrosine (G-J) and Alexa-labelled secondary
antibodies to visualise microtubule and focal complexes,
respectively. Images were taken with a confocal fluorescence
microscope; images in I and J represent vertical sections of
individual cells illustrated in C and D, respectively. Bar, 20 m m. 
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with TC45 PTP (Tiganis et al., 1999), the purified EphA3 ID was
able to rephosphorylate tyrosine residues upon the addition of
ATP and Mg2+, indicating that the kinase was functional (Fig.
6A). Analysis by mass spectrometry of tryptic peptides of the
phosphorylated and rephosphorylated EphA3 ID unambiguously
confirmed that the juxtamembrane tyrosines Y596, Y602 and the
kinase activation loop tyrosine 779 were phosphorylated in the
recombinant protein (M. L., unpublished data). Screening of
approximately 2· 105 plaques yielded a single clone
corresponding to the adapter protein CrkII (Matsuda et al.,
1992).
Ephrin-A5-induced recruitment of Crk in 293T cells
depends on EphA3 kinase activity 
In lysates from LiBr melanoma cells and from EphA3-
transfected 293T cells, Crk is associated with tyrosine-
phosphorylated EphA3 (Fig. 6B-F). Immunoprecipitation of
whole-cell lysates suggested that LiBr melanoma cells contain
discernible levels of endogenous Crk and EphA3 (Fig. 6B,
bottom panels). Endogenous EphA3 was apparent in anti-Crk
immunoprecipitates from ephrin-A5-stimulated LiBr cells, but
was undetectable in lysates of nonstimulated cells (Fig. 6C, top
panel). Furthermore, exposure of EphA3-expressing 293T cells
to increasing concentrations of surface-bound ephrin-A5
resulted in association of CrkII with the receptor, readily
noticeable at surface concentrations above 0.18 ng/mm2,
equivalent to 2 nM ephrin-A5. By comparison, a slightly
reduced level of EphA3 was detected in anti-Crk
immunoprecipitates of cells that had been stimulated with a
comparable concentration (10 nM) of preclustered ephrin-A5
Fc in solution (Fig. 6C). The association of EphA3 with Crk
was apparent in stably transfected 293T cells within 1 minute
of ephrin-A5 Fc addition and increased to maximal levels
30 minutes after stimulation (Fig. 6D). In agreement
with previous studies indicating ligand-independent
autophosphorylation of EphA3 at high receptor density
(Lackmann et al., 1998), anti-PY western blots of anti-EphA3
immunoprecipitates from transiently transfected 293T cells
revealed substantial receptor autophosphorylation in the
absence of ligand (Fig. 6E, middle panel). Phenylalanine
mutation of the EphA3 tyrosine Y779 (activation loop)
reduced the phosphotyrosine level, whereas mutation of the
juxtamembrane tyrosines Y596 and Y602 had little effect.
Mutation of both (2 · YF) or of all three tyrosines (3 · YF)
reduced the anti-PY signal to background levels (Fig. 6E,
middle panel). Western blot analysis of anti-Crk
immunoprecipitates from 293T cell lysates suggested
association of EphA3 with CrkII in ephrin-A5-stimulated,
EphA3-transfected cells. Interestingly, a comparable amount
of EphA3 coprecipitated in Y596 and Y602 mutant EphA3-
expressing cells was, in both cases, at higher levels than in
Fig. 4. EphA3 juxtamembrane and activation loop tyrosines are required for sequential
cell rounding and de-adhesion of EphA3 transfected 293T cells. 293T cells were
transiently transfected either with pEGFP-actin (Clontech) alone (B, GFP-actin), or in
addition to either wild-type (A, w/t) or mutant EphA3 with tyrosine to phenylalanine
mutations at position 596 (Y596F), 602 (Y602F), 779 (Y779F), 596 and 602 (2 · YF) or
596, 602 and 779 (3· YF) as indicated. Transfected cells on fibronectin-coated glass
coverslips were stimulated with soluble clustered ephrinA5 Fc (1.5 m g/ml). Control
samples were incubated with a 50-fold molar excess of soluble monomeric ephrin-A5 as
inhibitor (B, w/t + Inhibitor) 30 minutes before addition of preclustered ephrin-A5. Cells
were surveyed by confocal microscopy 10 minutes before and 50 minutes after the
addition of ephrin-A5 Fc, and photos were taken at representative time periods selected.
Bar, 20 m m.
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nonstimulated cells (Fig. 6E). By contrast, Crk association
with the receptor was not evident in samples from Y779F,
2 · YF or 3 · YF mutant EphA3-expressing cells. The sequence
motifs encompassing the EphA3 juxtamembrane tyrosines
accommodate potential YXXP Crk SH2 domain docking sites
(Birge et al., 1993). We further examined whether these motifs
are involved in CrkII binding: A Sepharose-tethered 2 · Y
phosphopeptide, but not the nonphosphorylated counterpart,
was able to bind CrkII from EphA3-transfected 293T lysates
(Fig. 6F, left panel). However, no significant effect was
observed when phosphopeptides corresponding to the
juxtamembrane or activation loop sequences were added to
CrkII immunoprecipitation reactions (Fig. 6F, right panel). 
A dominant-negative Crk SH3 domain mutant abrogates
ephrin-A5-mediated cell rounding and actin cytoskeletal
changes
To assess the functional relevance of ephrin-A5-induced
recruitment of Crk to EphA3, we monitored actin-cytoskeletal
changes in EphA3-overexpressing 293T cells, which were
transfected with either w/t Crk, a dominant-negative Crk SH3
domain mutant (SH3* Crk), or both expression constructs.
Overexpression of w/t Crk induces membrane spreading and
membrane ruffling (Dolfi et al., 1998) by recruitment of
DOCK180 to the Crk/p130CAS complex (Kiyokawa et al., 1998),
whereas SH3 domain mutated Crk causes abrogation of
membrane ruffling and spreading (Nakashima et al., 1999). In
agreement, untreated w/t Crk-transfected EphA3-293T cells
reveal extensive spreading and ruffling, whereas SH3* Crk-
transfected cells lack any signs of ruffling (Fig. 7, –) and display
distinct, dendrite-like actin-rich cell processes. Treatment with
preclustered ephrin-A5 Fc leads to rounding, contraction of the
actin cytoskeleton and loss of membrane ruffles at comparable
levels (Fig. 7, +) in w/t-Crk overexpressing and control cells. By
contrast, SH3*Crk-expressing cells appear not to respond to
ephrin-A5 treatment and do not change their morphology during
the experiment. Cotransfection of SH3* Crk together with w/t
CrkII rescues the SH3* phenotype, and membrane ruffling and
spreading of the untreated cells resembles that of w/t CrkII-
transfected cells. Importantly, these cells regain their reactivity
to ephrin-A5 stimulation and respond with pronounced cell
rounding and contraction of the actin cytoskeleton. Staining of
transiently transfected cells with anti-myc Mab confirms the
expression of myc-tagged Crk constructs and suggests that,
following ephrin-A5 stimulation, Crk colocalises with the
cortical actin ring. By contrast, nonstimulated (not shown) or
SH3* Crk-transfected cells display diffuse cytoplasmic anti-myc
(Crk) staining (Fig. 7, +, anti-myc).
Modulation of Rho activity following EphA3 activation
relies on a functional Crk SH3 domain
The distinctive effects of ephrin stimulation on the
cytoskeleton prompted us to examine the involvement of RhoA
as a downstream effector molecule. We examined cell lysates
Journal of Cell Science 115 (5)
Fig. 5. Dose-dependent inhibition of cell adhesion and spreading by
surface-bound ephrin-A5. (A) Capacity of Protein A-coated 96-well
plates for Ephrin-A5 Fc (j) and of Protein A-bound ephrin-A5 for
EphA3 (s). Ephrin-A5 Fc was applied at indicated concentrations and
bound protein in the supernatant was estimated by Biacore analysis. To
confirm the competence of tethered ephrin-A5 to interact with the
receptor, the nonbound fraction of EphA3 (2 m g/ml) after incubation
on ephrin-A5-coated wells was determined by Biacore analysis. The
amount of bound EphA3 estimated from this assay is shown (s).
(B) 293T cells, transiently transfected with w/t or mutant EphA3, and
pEGFP-actin were plated (5· 104cells/well) onto wells coated with
ephrinA5-Fc at the indicated densities (ng/mm2). After 5 hours,
adherent cells were fixed with 4% paraformaldehyde and examined by
fluorescence microscopy. Sections of w/t EphA3-transfected cells are
shown. Bar, 20 m m. (C) Following microscopy, adherent cells were
quantified using crystal violet staining. Cell attachment is expressed as
a percentage (mean±s.d. from three independent assays) relative to
adhesion seen on non-ephrin-A5-coated wells; d, w/t EphA3; m,
Y596F EphA3; j, Y602F EphA3; h, Y 779F EphA3; n,
Y596F+Y602F EphA3.
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of parental or EphA3 293T cells for levels of activated Rho,
precipitated with the recombinant RhoA binding domain
(RBD) of rhotekin (Ren et al., 1999). Ephrin-A5 Fc stimulation
consistently resulted in a transient increase in RBD-bound,
active Rho to maximal levels within 5 minutes (Fig. 8A). No
significant changes in the level of RBD-bound Rho were
observed in the parental 293T cells (Fig. 8B). Activation in
suspended EphA3 293T cells occurred with very similar
kinetics, although peak levels of active RhoA were observed
slightly earlier than in adherent cells, 3 minutes after
stimulation (Fig. 8C). The rise in active Rho followed a decline
to basal levels 10 minutes after ephrin-A5 addition.
Importantly, the rise in active Rho was not seen in ephrin-A5-
stimulated EphA3 293T cells expressing dominant-negative
SH3* Crk (Fig. 8E), whereas expression of w/t Crk did not
affect the kinetics of Rho activation (Fig. 8D). 
To assess the involvement of RhoA functionally, we treated
EphA3-293T cells either with recombinant Clostridium
botulinum C3 toxin (Fig. 9A-E), which ribosylates and
specifically inhibits Rho activity (Leng et al., 1998), or with Y-
27632 (Fig. 9F), a specific Rho kinase inhibitor (Uehata et al.,
1997), previously shown to inhibit ROCK-dependent
membrane blebbing (Coleman et al., 2001). We adjusted the
concentration of C3 to produce modest actin cytoskeletal
changes without causing EphA3-293T cell rounding (Fig. 9C).
Exposure of cells to this concentration of C3 reduced the level
of active Rho significantly, as indicated by 70% reduced levels
of Rho available for radioactive ADP ribosylation (Fig. 9E).
C3 treatment under these conditions completely abrogated
ephrin-A5-mediated cell rounding (Fig. 9D), thus supporting
the involvement of Rho in this response. To examine the role
Fig. 6. Crk rapidly binds the phopshorylated EphA3 ID and is able to
distinguish between ligand-independent and ligand-mediated receptor
phosphorylation. (A) Coomassie-stained SDS PAGE (top) and anti-PY
western blot (bottom) illustrating the phosphorylated EphA3 ID as
purified from the E. coli (1), dephosphorylated by TC45Pase (2) and
rephosphorylated by the addition of ATP and Mg2+ (3). (B) Ephrin-A5-
dependent association of Crk with endogenous EphA3 in LiBr
melanoma cells. Adherent cultures of LiBr cells were treated for 10
minutes with preclustered ephrin-A5 Fc (+) or left untreated (–).
Endogenous Crk in cell lysates was immunoprecipitated with anti-CrkII
antibody and western blots probed with the same antibody to detect
total CrkII or with anti-EphA3 antibodies to detect CrkII-associated
EphA3. Parallel samples were immunoprecipitated with anti-EphA3
Mab and western blots probed for EphA3 and phosphotyrosine as
indicated. (C) Dose-response of ephrin-A5 stimulated CrkII recruitment
to EphA3. EphA3-transfected 293T cells were transferred to tissue
culture wells containing surface-bound ephrin-A5 Fc at the indicated
concentrations for 10 minutes, and endogenous CrkII in the cell lysates
was immunoprecipitated with anti-Crk antibody. In parallel samples,
the cells left in suspension were left untreated (–) or stimulated with 10
nM preclustered ephrin-A5 in solution (+). Blots of whole-cell lysates
and of precipitated proteins were probed with anti-EphA3 and anti-
CrkII antibodies as indicated. (D) Time course of CrkII binding to
EphA3. EphA3 was (co) immunoprecipitated from lysates of EphA3
293T cells, which had been treated for the indicated times with 1.5
m g/ml of preclustered ephrin-A5 Fc, and analysed by western blot with
anti- EphA3 and anti-phosphotyrosine antibodies as indicated. (E) 293T
cells were left nontransfected (nil) or were transiently transfected with
cDNAs encoding single, double (2· ) or triple (3· ) Tyr (Y)-Phe(F)
mutants of EphA3. Anti-EphA3 immunoprecipitates from lysates of
cells stimulated for 10 minutes with preclustered ephrin-A5 Fc (+) or
left untreated (–), were analysed by western blot probed with anti-PY
antibody. As loading control the total lysate was analysed by anti
EphA3 western blot. Endogenously expressed Crk was
immunoprecipitated from the same lysates and analysed by
immunoblot for associated EphA3. (F) Crk was extracted from lysates
of Crk-transfected 293T cells using Sepharose-coupled phosphopeptide
Y596, 602P (Y2· P-Seph) or the nonphosphorylated peptide as control
(Y2· -Seph) and analysed by western blot using the anti-Crk
monoclonal antibody (left panel). The CrkII band in the crude cell
lysate is shown in a parallel lane. Lysates from ephrin-A5 Fc stimulated
cells were immunoprecipitated with anti-Crk antibody in the absence
(nil) or presence of 50 m M of EphA3-derived phosphopeptides as
indicated in the figure (right panel). Immunoprecipitates were analysed
by western blots probed with antibodies to EphA3.
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of ROCK, a downstream effector of active RhoA (Watanabe et
al., 1999), we exploited time-lapse microscopy to monitor
ephrin-A5-induced membrane blebbing in parental or EphA3-
293T cells that were treated with the ROCK inhibitor Y-27632.
Treatment of EphA3 293T cells with the Rho kinase inhibitor
Y-27632 also completely abrogated ephrin-A5-induced
membrane blebbing (Fig. 9F). Interestingly, this inhibition
of ROCK activity had little effect on cell rounding (see
http://www.ludwig.edu.au/addinfo/Figure9Finhib.mpg). For
comparison we treated EphA3 293T cells with LY 294002,
to inhibit phosphoinositide-3-kinase, which is involved in
signalling pathways that effect cytoskeletal changes (Hall,
1998; Rodriguez-Viciana et al., 1997), and recently shown to
modulate integrin activity downstream of EphA8 (Gu and
Park, 2001). Although LY 294002 treatment inhibited ephrin-
triggered membrane blebbing, the effect was less pronounced
than inhibition by Y-27632 (Fig. 9F). 
Discussion
Eph or ephrin overexpression in tumours such as malignant
melanoma (Chiari et al., 2000; Easty et al., 1995) could
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Fig. 7. Dominant-negative SH3* CrkII abrogates ephrin-A5-
mediated cytoskeletal changes. EphA3 293T cells (control) were
transiently transfected with myc-tagged, w/t CrkII, dominant-
negative SH3* CrkII or both w/t and SH3* CrkII as indicated.
Parallel cultures of stimulated (+) or nonstimulated (–) cells were
fixed in 4% PFA. Cells were stained with rhodamine-phalloidin
(Phalloidin) or anti-Myc antibody (anti-Myc) to monitor the actin
cytoskeleton or CrkII derived proteins, respectively. 
Fig. 8. Ephrin-A5 stimulation of EphA3-expressing 293T cells
mediates a rapid increase of active Rho A. The levels of active RhoA
in parental (B) or EphA3-293T cells (A,C-E) transfected with w/t
Crk (D) or SH3* Crk (E) as indicated, and which had been treated as
adherent (A,B,D) or suspension (C) cultures with preclustered
ephrin-A5, were analysed at the indicated times by precipitating
GTP-bound RhoA with GST-RBD. Precipitated proteins and aliquots
of the total lysates were analysed by immunoblotting with an anti-
RhoA Mab. The intensity of bands representing active RhoA (RhoA-
GTP) was normalised by comparison with Rho levels in
corresponding total lysates using densitometry, and is indicated
relative to baseline levels (given the arbitrary value ‘1’) in the
absence of ephrin-A5 stimulation. Each result represents the mean
and s.d. from a minimum of three independent experiments. 
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indicate relevance in tumour progression and metastasis
(Dodelet and Pasquale, 2000; Easty et al., 1999; Vogt et al.,
1998). Melanomas derive from neural crest-derived skin
melanocytes, and although Eph signalling is crucial for neural
crest migration (Krull, 1998; Wang and Anderson, 1997), Eph
receptors are not expressed in mature melanocytes (Chiari et
al., 2000; Easty et al., 1999). The notion that unscheduled
expression of Eph RTKs and ephrins in melanomas may
contribute to the malignant phenotype encouraged us to study
responses of EphA3 expressing and nonexpressing melanoma
cells to ephrin-A5 stimulation. 
It is well established that signals from within the cells and
cross-talk with RTKs, including Eph receptors (Schmucker,
2001), modulate the activity and avidity of adhesion receptors
and thus the adhesive properties of cultured cells (Gumbiner,
1996). We show that, in EphA3-expressing adherent melanoma
cell lines and in EphA3-overexpressing 293T cells, ephrin-A5-
induced receptor activation promotes sequential retraction of
cell processes, cell rounding, membrane blebbing and
detachment. Functional and biochemical analysis of the
underlying mechanisms reveals that these morphological
changes are mediated through recruitment of CrkII to ligand-
activated EphA3 and a concurrent, transient activation of
RhoA. A rapid condensation of the actin cytoskeleton and
microtubule network and a concurrent loss or re-distribution,
or both, of focal contacts from the cell periphery (Fig. 3D-J)
suggests that, like other Eph-like RTKs (Miao et al., 2000;
Schmucker, 2001), ephrin-A5-activated EphA3 modulates
focal adhesion signalling pathways. Although these cellular
responses are reminiscent of the morphological events
occurring during apoptosis (Jacobson et al., 1997), our
experiments show that activation of EphA3 does not affect cell
viability (Fig. 2D). In contrast to apoptotic blebbs, which are
static and often detach from the cell surface, ephrin-A5 triggers
highly dynamic, spherical membrane protrusions that do not
lead to cell fragmentation. Membrane blebbing is observed
frequently in living cells during mitosis, cell spreading and
migration and results from increases in the intracellular
pressure and extensive changes to the actin cytoskeleton
(Hagmann et al., 1999). Several recent reports suggest that
increased contractility of the actomyosin network, due to
increased phosphorylation of myosin light chains by myosin
light chain kinase (Mills et al., 1998) and ROCK (Coleman et
al., 2001), are essential in both apoptotic and nonapoptotic
blebbing (Hagmann et al., 1999). 
Tissue culture surfaces decorated with ephrin-A5 at defined
densities allowed us to examine how activation of EphA3
effects the adhesion of detached cells. At 0.18 ng ephrin-
A5/mm2 (~2 nM), 50% of the cells remained in suspension
(Fig. 5A,B). This concentration agrees well with the low
nanomolar affinity of the ephrin-A5/EphA3 interaction
(Lackmann et al., 1997), showing that these surfaces provide
a physiologically relevant model of EphA3 stimulation. With
decreasing ephrin-A5 density, w/t cells were able to adhere and
gradually spread out (Fig. 5B). Importantly, Hattori et al.
showed recently that the high-affinity ephrin-A2/EphA3
interaction triggers a specific ADAM metalloprotease-
catalysed ephrin-cleavage at sites of cell-cell contact, which
allows cell repulsion to occur (Hattori et al., 2000). Increased
adhesion of several cell lines to ephrin-B Fc surfaces, prepared
by passive adsorption onto nitrocellulose, has been linked to
Fig. 9. Inhibition of Rho and ROCK activities abrogate ephrin-A5-
mediated cell rounding and membrane blebbing. EphA3 293T cells (A-
D) were treated with 10 m M C3 transferase exoenzyme overnight (C,D)
and control cells left untreated (A,B). Parallel cultures of stimulated (+)
or nonstimulated (–) cells were fixed in 4% PFA and stained with
rhodamin-phalloidin. (E) Treatment with C3 transferease reduces RhoA
available for ribosylation. Lysates fromEphA3 293T cells with (+) or
without (–) overnight C3 transferase treatment were used for ADP
ribosylation assays in the presence of radioactive 32P-NAD. RhoA-
associated radioactivity was quantified after SDS-PAGE and
autoradiography (top) by densitometry. Mean and s.d. from two
independent experiments are shown (bottom). (F) Cell blebbing in
EphA3-293T cells, left untreated or after pretreatment with 10 m M
ROCK inhibitor Y-27632 or 10 m M PI3 kinase inhibitor LY 294002 (2
hours), was monitored by time-lapse microscopy. As control, blebbing
in parental nontransfected 293T cells is shown. Representative fields
containing approximately 100 cells were monitored for 10 minutes
before and 50 minutes after stimulation. Total and blebbing cells were
counted by an observer blinded to experimental conditions. Values
represent mean percentages and s.d. (three independent experiments) of
cells that commenced blebbing following addition of ephrin-A5.
Supplemental videos of time courses illustrating responses of EphA3-




EphB1-mediated integrin activation (Becker et al., 2000; Stein
et al., 1998a), but this may result from mechanical tethering
through EphB/ephrinB interactions (Miao et al., 2000). Some
of the apparent differences in these reports may also relate to
the different ephrin-coupling strategies yielding different
densities of functional ephrin. 
Two conserved tyrosines in the juxtamembrane region of Eph
receptors reportedly function as SH2-domain docking sites for
known signalling molecules including Fyn (Ellis et al., 1996), Src
(Zisch et al., 2000), RasGAP, (Holland et al., 1997), SHEP-1
(Dodelet et al., 1999) and Nck (Stein et al., 1998b), but little is
known about the functional consequences of these interactions.
Together with the activation-loop tyrosine, these residues also
function to regulate kinase activity, and their phosphorylation is
required for full enzyme activity (Binns et al., 2000; Zisch et al.,
2000). In agreement, we assigned these tyrosines (EphA3 Y596,
Y602 and Y779) as the prominent autophosphorylation sites of
EphA3 (M. L., unpublished). Exposure of EphA3-expressing w/t
or mutant cells (Y596F, Y602F, Y779F, 2· YF and 3· YF) to
either surface-tethered or to clustered ephrin-A5 in solution
confirmed that the cellular response to EphA3 activation is
critically dependent on their phosphorylation and a resultant
functional EphA3 kinase (Figs 3, 4; Fig. 5C; Fig. 6E).
Phenylalanine substitutions of individual juxtamembrane
tyrosines reduced ephrin-A5 mediated repulsion (Fig. 5C) and
delayed cell rounding, whereas mutation of the activation-loop
tyrosine, of both juxtamembrane tyrosines, or of all three
tyrosines together ablated ephrin-A5-induced cell rounding and
repulsion and reduced the kinase activity to background.
Analysis of the signalling events following EphA3 activation
resulted in two key observations: a dose-dependent recruitment
of Crk to ligand-stimulated EphA3 and a rapid modulation of Rho
activity. We initially identified Crk as a binding partner for
phosphorylated EphA3, by probing a cDNA expression library
with recombinant EphA3 ID. We confirmed this interaction by
coprecipitation of EphA3 together with endogeneous Crk in
immunoprecipitates from ephrin-A5-stimulated LiBr melanoma
cells (Fig. 6B), and from ligand-stimulated EphA3 293T cells
(Fig. 6C-F). Binding of the recombinant Crk SH2 domain to the
EphB3 juxtamembrane PY motif containing two consecutive
‘YXXP’ Crk SH2 domain binding sites has been reported (Hock
et al., 1998). In agreement, we extracted CrkII from 293T cell
lysates using a phosphopeptide comprising the corresponding
EphA3 sequence, and site-directed mutagenesis of both of these
consensus Crk binding sites together ablated the EphA3/Crk
interaction. Interestingly, addition of excess juxtamembrane
phosphopeptide to the immunoprecipitation reaction did not
significantly reduce the amount of coprecipitated EphA3. We
suggest two alternative explanations for these observations.
Either the inability to disrupt the CrkII/EphA3 interaction by
peptide competition indicates that stable CrkII recruitment occurs
indirectly via an as yet unidentified component. This would imply
that the interaction observed during our expression cloning
strategy and the CrkII ‘pull down’ with Sepharose-tethered 2· Y
phosphopeptide are due to the fortuitous use of the CrkII
consensus sequence. Alternatively, CrkII binding via an SH2
interaction may require a defined configuration of ligand-induced
EphA3 clusters, which cannot be disrupted by a short consensus
phosphopeptide. Importantly, in EphA3-transfected 293T cells,
CrkII binds prominently only to the ligand activated, and not to
the autophosphorylated receptor (Fig. 6B-E). Furthermore, the
increase of EphA3-associated CrkII during ephrin-A5 stimulation
closely parallels the cellular response monitored by time-lapse
microscopy (Fig. 4; Fig. 6D). Perhaps in a cellular context CrkII
is recruited to an EphA3 docking site that is functional only at a
critical density or configuration of the EphA3 aggregate, which,
in turn is determined by the concentration or density of
preclustered or membrane-anchored ephrin-A5. This notion is in
agreement with an earlier report showing that the composition of
EphB1 signalling complexes and resulting cellular responses
depend on the oligomeric state of the interacting ephrin-B1 (Stein
et al., 1998a). Importantly, our experiments show that recruitment
of Crk to EphA3 is accompanied by a concurrent, transient
increase in active RhoA. Both events are essential in ephrin-A5-
induced rounding and detachment of EphA3-bearing cells and are
not reliant on cell adhesion. An increasing body of evidence
implicates CrkII and its association with p130CAS in signal-
transduction processes that regulate cytoskeletal rearrangements
during cell adhesion and migration (Arai et al., 1999; Cary et al.,
1998; Klemke et al., 1998). In support of our observations, a role
for the Crk/p130CAS complex in regulating cell spreading was
reported (Vuori et al., 1996) and Crk-induced membrane ruffling,
cell spreading and Jun N-terminal kinase activation is blocked by
a dominant-negative form of Rac. This suggests a linear pathway,
where recruitment/activation of Rho-family GTPases to the
Crk/p130CAS complex leads to JNK activation (Dolfi et al., 1998).
Increasing evidence implies Eph receptor signalling upstream of
this pathway, including EphB2, which modulates the activity of
Erk2 and JNK1 (Zisch et al., 2000), and EphB1, which recruits
a complex containing Nck, p62dock and RasGAP and mediates
JNK activation (Holland et al., 1997; Stein et al., 1998c). The
guanine nucleotide exchange factor (GEF) ephexin, which has
GEF activity for Rho, Rac and Cdc42, and in retinal ganglion
cells is constitutively associated with EphA4, provides further
evidence for communication from Eph RTKs via RhoA to the
cytoskeleton (Shamah et al., 2001). Our observation, that
overexpression of SH3-domain mutated, dominant-negative
CrkII affects ephrin-A5 induced RhoA activation, could indicate
that CrkII acts upstream of Rho as a molecular link to effect
EphA3-induced contraction of the cytoskeleton. Supporting this
notion, it was shown recently that activation of Rho and Rho
kinase is responsible for ephrin-A5-induced growth cone collapse
(Wahl et al., 2000). 
Adhesion and de-adhesion of cells to the substratum is
regulated by a tightly controlled interchange of signals from
several extracellular and intracellular origins, and their
deregulation or uncoupling has been correlated with
tumourigenesis and metastasis (Giancotti, 1997). Although an
essential role of Eph RTKs in modulating actin dynamics, in
particular in growing axons, is now well recognised
(Schmucker, 2001), our observations indicate that activated
EphA3 triggers CrkII- and Rho-mediated cytoskeletal changes
and detachment, but not apoptosis. As the unscheduled
expression of EphA3 and ephrins correlate with melanoma
progression, we speculate that this response to EphA3
activation may be one of the initiating events leading to
melanoma metastasis. It is noteworthy that, although ephrin-
A5-induced detachment was not observed in EphA3-negative
melanoma cells, the intensity of the response varied between
EphA3-positive, strongly adherent and less strongly adherent
melanoma cell lines. Interestingly, some of the less adherent
LiBr cells were routinely rounded before stimulation with
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exogenous ephrin, indicating potential autocrine EphA3
activation by endogenous ephrins. In support of this notion we
found comparable cell-surface expression levels of EphA3 and
ephrin-A on these cells. 
Both CrkII and RhoA have central roles in the regulation of
the dynamic actin signalling network. Reagents that modulate
GTPase activities and affect the formation of CrkII signalling
complexes induce the disassembly of focal adhesions and loss
of cell substratum contact (Klemke et al., 1998; Escalante et
al., 2000; Ren et al., 1999). Consistent with this concept,
results presented in this study imply that recruitment of Crk to
the EphA3 receptor and transient activation of Rho facilitate
ephrin-A5-induced cell rounding, membrane blebbing and de-
adhesion. CrkII and RhoA are candidates for mediating the
communication between the ligand-activated EphA3 receptor
and the actin cytoskeleton. 
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